Overview

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Status:
RECRUITING
Trial end date:
2027-01-31
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.
Phase:
PHASE3
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Treatments:
Cenobamate